Peer‑Reviewed Evidence
for Bioelectric Therapy.
Pulsed Shortwave Therapy (PSWT) supported by clinical studies demonstrating reductions in pain, inflammation, and opioid use across musculoskeletal and post-surgical populations.
Evidence Overview
Clinical studies and real-world evidence support the use of Pulsed Shortwave Therapy (PSWT) for studied pain and function outcomes.
Mechanism of Action
PSWT therapy interacts with biological systems at the cellular level, influencing ion channels and signaling pathways involved in pain and inflammation.
Modulation of voltage-gated ion channels
Reduction in inflammatory signaling pathways
Improved microcirculation and oxygenation
Support for cellular repair processes
Observed Clinical Outcomes
Reduction in pain intensity observed in clinical studies
Improved physical function and mobility reported by patients
Improved sleep quality associated with pain reduction
Reduced analgesic use observed in selected studies
Reduced postoperative pain and edema in surgical studies
Improved recovery timelines demonstrated in post-surgical populations
Study Highlights
Safety and Tolerability
Non-invasive, drug-free therapy
Drug-free with no known drug interactions
Supports extended continuous or intermittent use
Consult device instructions for use
Compatible with standard care protocols
Clinical Applications
Regulatory Status
Electrome's devices are based on FDA-cleared Pulsed Shortwave Therapy (PSWT) technology for their respective pain-related indications.
Bring Evidence‑Based, Drug‑Free Therapy to Your Patients
Join the growing number of providers integrating clinically studied, non-invasive pain therapy into their practice.